QLS12004
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 25, 2023
A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
Metastases • New P1 trial • Breast Cancer • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • HER-2
1 to 1
Of
1
Go to page
1